Download PDF
Thromb Haemost 1966; 15(01/02): 284-293
DOI: 10.1055/s-0038-1649428
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

A Serial Micro-Fibrinolysis Test and Its Use in Rats with Liver-Bypass[*]

S Wasantapruek
1   Department of Medicine, University of Colorado School of Medicine, Denver / Colorado
,
K. N von Kaulla
1   Department of Medicine, University of Colorado School of Medicine, Denver / Colorado
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

    Permissions and Reprints

Summary

A micro-euglobulin lysis test is described for serial testing in individual rats. With the method it was shown that the rat a) responds well with a fibrinolytic reaction to carbachol, b) that a liver-bypass in this animal produces a sustained fibrinolytic reaction which c) after subsiding can be re-established by carbachol and that d) the fibrinolytic phase in rats with liver-bypass lasts longer after preceding splenectomy and adrenalectomy.

* This work was supported by grants from the American Heart Association and the National Heart Institute, U. S. Public Health Service (HE 5538 and 5 T1 — HE 5638).


 

  • References

  • 1 von Kaulla K. N. Chemistry of Thrombolysis. Human Fibrinolytic Enzymes. Chapter 20. C.C. Thomas Publisher; Springfield: 1963
    Google Scholar
  • 2 Genton E, Kern F, von Kaulla K. N. Fibrinolysis Induced by Pressor Amines. Amer. J. Med 31: 564 1961;
    CrossrefPubMedGoogle Scholar
  • 3 Rahn B, von Kaulla K. N. Pharmacological Induction of Fibrinolytic Activity in the Dog. Proc. Soc. exp. Biol. (N. Y) 115: 359 1964;
    CrossrefPubMedGoogle Scholar
  • 4 Starzl T. E, Marchioro T. L, von Kaulla K. N, Hermann G, Brittain R. S, Waddell W. R. Homotransplantation of the Liver in Humans. Surg. Gynec. Obstet 117: 659 1963; von Kaulla, K.N., T.E. Starzl, H. Kay: In preparation.
    PubMedGoogle Scholar
  • 5 von Kaulla K. N, Schulz R. L. Methods of the Evaluation of Human Fibrinolysis. Studies with Two Combined Techniques. Amer. J. Clin. Path 29: 104 1958;
    PubMedGoogle Scholar
  • 6 Michaelis L. Der Azet at -V er onalpuffer. Biochem. Z 234: 139 1931;
    PubMedGoogle Scholar
  • 7 Ashwin J. G, Coughlin W. R. Fibrinolytic Action of Reserpine in Rats. Canad. J. Physiol. Pharmacol 42: 153 1964;
    CrossrefPubMedGoogle Scholar
  • 8 Cho M. H, Ghoy W. Induction of Increased Fibrinolytic Activator in Plasma by Various Drugs. Thrombos. Diathes haemorrh. (Stuttg) 11: 372 1964;
    PubMedGoogle Scholar
  • 9 Norman P. S. Studies of the Plasmin System. I. Measurement of Human and Animal Plasminogen. Measurement of an Activator in Human Serum. J. exp. Med 106: 423 1957;
    PubMedGoogle Scholar
  • 10 Ungar G, Damgaard E. Studies of Fibrinolysin-Antifibrinolysin System in Serum. I.Action of the Anterior Pituitary, Adrenal Cortex and Spleen. J. exp. Med 93: 89 1951;
    PubMedGoogle Scholar
  • 11 Nolf P. Les modifications de la coagulation du sang chez le chien après l’extirpation du foie. Arch. int. Physiol 03: 1 1905;
    PubMedGoogle Scholar
  • 12 Kwaan H. G, McFadzean A. J. S, Cook J. Plasma Fibrinolytic Activity in Cirrhosis of the Liver. Lancet I: 132 1956;
    PubMedGoogle Scholar
  • 13 Astrup T, Rasmussen J, Amery A, Poulsen H. S. Fibrinolytic Activity of Cirrhotic Liver. Nature 185: 619 1960;
    CrossrefPubMedGoogle Scholar
  • 14 Weiner M. The Fibrinolytic Response to Nicotinic acid in Abnormal Liver States. Amer. J. med. Sei 246: 294 1963;
    CrossrefPubMedGoogle Scholar
  • 15 Fletcher A. P, Biederman O, Moore D, Alkjaersig N, Sherry S. Abnormal Plasminogen-Plasmin System Activity (Fibrinolysin) in Patients with Hepatic Cirrhosis : Its Cause and Consequences. J. clin Invest 43: 681 1964;
    CrossrefPubMedGoogle Scholar
  • 16 Rousselot L. M, Casez B, Grossi G. E. L’inactivation par le foie des enzymes fibrinoly tiques. Presse méd 71: 2678 1963;
    PubMedGoogle Scholar